{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:59:48Z","timestamp":1767992388075,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T00:00:00Z","timestamp":1170460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T00:00:00Z","timestamp":1170460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00213-007-0718-y","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T07:17:42Z","timestamp":1170487062000},"page":"407-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cataleptic effects of \u03b3-hydroxybutyrate (GHB), its precursor \u03b3-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348"],"prefix":"10.1007","volume":"192","author":[{"given":"Wouter","family":"Koek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Coop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,3]]},"reference":[{"key":"718_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","volume":"30","author":"J Benavides","year":"1982","unstructured":"Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, Maitre M (1982) High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 30:953\u2013961","journal-title":"Life Sci"},{"key":"718_CR2","first-page":"114","volume":"262","author":"G Bonanno","year":"1992","unstructured":"Bonanno G, Raiteri M (1992) Functional evidence for multiple gamma-aminobutyric acid B receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther 262:114\u2013118","journal-title":"J Pharmacol Exp Ther"},{"key":"718_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","volume":"428","author":"MA Carai","year":"2001","unstructured":"Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, Minardi G, Gessa GL (2001) Role of GABA(B) receptors in the sedative\/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315\u2013321","journal-title":"Eur J Pharmacol"},{"key":"718_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1124\/jpet.102.047860","volume":"305","author":"LP Carter","year":"2003","unstructured":"Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668\u2013674","journal-title":"J Pharmacol Exp Ther"},{"key":"718_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/jpet.103.058909","volume":"308","author":"LP Carter","year":"2004","unstructured":"Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, France CP (2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors. J Pharmacol Exp Ther 308:182\u2013188","journal-title":"J Pharmacol Exp Ther"},{"key":"718_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1124\/jpet.104.077578","volume":"313","author":"LP Carter","year":"2005","unstructured":"Carter LP, Wu H, Chen W, Matthews MM, Mehta AK, Hernandez RJ, Thomson JA, Ticku MK, Coop A, Koek W, France CP (2005) Novel {gamma}-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists. J Pharmacol Exp Ther 313:1314\u20131323","journal-title":"J Pharmacol Exp Ther"},{"key":"718_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejphar.2006.03.039","volume":"538","author":"LP Carter","year":"2006","unstructured":"Carter LP, Chen W, Coop A, Koek W, France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85\u201393","journal-title":"Eur J Pharmacol"},{"key":"718_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0031-9384(98)00062-6","volume":"64","author":"G Colombo","year":"1998","unstructured":"Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998) Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293\u2013302","journal-title":"Physiol Behav"},{"key":"718_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0014-2999(94)90727-7","volume":"263","author":"A Fassio","year":"1994","unstructured":"Fassio A, Bonanno G, Cavazzani P, Raiteri M (1994) Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol 263:311\u2013314","journal-title":"Eur J Pharmacol"},{"key":"718_CR10","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/jm00017a015","volume":"38","author":"W Froestl","year":"1995","unstructured":"Froestl W, Mickel SJ, Hall RG, von Sprecher G, Strub D, Baumann PA, Brugger F, Gentsch C, Jaekel J, Olpe HR, Rihs G, Vassout A, Waldmeier PC, Bittiger H (1995a) Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J Med Chem 38:3297\u20133312","journal-title":"J Med Chem"},{"key":"718_CR11","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1021\/jm00017a016","volume":"38","author":"W Froestl","year":"1995","unstructured":"Froestl W, Mickel SJ, von Sprecher G, Diel PJ, Hall RG, Maier L, Strub D, Melillo V, Baumann PA, Bernasconi R, Gentsch C, Hauser K, Jaekel J, Karlssen G, Klebs K, Maitre L, Marescaux C, Pozza MF, Schmutz M, Steinmann MW, van Riezen H, Vassout A, Mondadori C, Olpe H-R, Waldmeier PC, Bittiger H (1995b) Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists. J Med Chem 38:3313\u20133331","journal-title":"J Med Chem"},{"key":"718_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1592\/phco.23.10.1205.32756","volume":"23","author":"DE Fuller","year":"2003","unstructured":"Fuller DE, Hornfeldt CS (2003) From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy 23:1205\u20131209","journal-title":"Pharmacotherapy"},{"key":"718_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0269881105049041","volume":"19","author":"A Gonzalez","year":"2005","unstructured":"Gonzalez A, Nutt DJ (2005) Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 19:195\u2013204","journal-title":"J Psychopharmacol"},{"key":"718_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00213-005-2165-y","volume":"180","author":"AK Goodwin","year":"2005","unstructured":"Goodwin AK, Froestl W, Weerts EM (2005) Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology (Berl) 180:342\u2013351","journal-title":"Psychopharmacology (Berl)"},{"key":"718_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1749-6632.2002.tb04186.x","volume":"965","author":"Y Itzhak","year":"2002","unstructured":"Itzhak Y, Ali SF (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci 965:451\u2013460","journal-title":"Ann N Y Acad Sci"},{"key":"718_CR16","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1111\/j.1460-9568.2003.03013.x","volume":"18","author":"K Kaupmann","year":"2003","unstructured":"Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der PH, Mosbacher J, Brauner-Osborne H, Waldmeier P, Bettler B (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722\u20132730","journal-title":"Eur J Neurosci"},{"key":"718_CR17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1124\/jpet.103.056093","volume":"308","author":"W Koek","year":"2004","unstructured":"Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, France CP (2004) Discriminative stimulus effects of gamma-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABA(A) and GABA(B) receptors. J Pharmacol Exp Ther 308:904\u2013911","journal-title":"J Pharmacol Exp Ther"},{"key":"718_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.105.096909","volume":"317","author":"W Koek","year":"2006","unstructured":"Koek W, Wu H, Coop A, France CP (2006) Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317:1\u20139","journal-title":"J Pharmacol Exp Ther"},{"key":"718_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-2999(93)90268-M","volume":"237","author":"M Lanza","year":"1993","unstructured":"Lanza M, Fassio A, Gemignani A, Bonanno G, Raiteri M (1993) CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol 237:191\u2013195","journal-title":"Eur J Pharmacol"},{"key":"718_CR20","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","volume":"38","author":"K Lingenhoehl","year":"1999","unstructured":"Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, Mosbacher J (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38:1667\u20131673","journal-title":"Neuropharmacology"},{"key":"718_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337\u2013361","journal-title":"Prog Neurobiol"},{"key":"718_CR22","first-page":"273","volume":"12","author":"M Mamelak","year":"1977","unstructured":"Mamelak M, Escriu JM, Stokan O (1977) The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry 12:273\u2013288","journal-title":"Biol Psychiatry"},{"key":"718_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-2999(96)00916-8","volume":"321","author":"P Mathivet","year":"1997","unstructured":"Mathivet P, Bernasconi R, De BJ, Marescaux C, Bittiger H (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67\u201375","journal-title":"Eur J Pharmacol"},{"key":"718_CR24","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/0028-3908(87)90108-0","volume":"26","author":"AK Mehta","year":"1987","unstructured":"Mehta AK, Ticku MK (1987) Baclofen induces catatonia in rats. Neuropharmacology 26:1419\u20131423","journal-title":"Neuropharmacology"},{"key":"718_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0278-5846(98)00043-8","volume":"22","author":"JF Navarro","year":"1998","unstructured":"Navarro JF, Pedraza C, Martin M, Manzaneque JM, Davila G, Maldonado E (1998) Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Prog Neuropsychopharmacol Biol Psychiatry 22:835\u2013844","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"718_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/alcalc\/34.1.15","volume":"34","author":"F Poldrugo","year":"1999","unstructured":"Poldrugo F, Addolorato G (1999) The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol 34:15\u201324","journal-title":"Alcohol Alcohol"},{"key":"718_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1192\/bjp.184.2.104","volume":"184","author":"J Rodgers","year":"2004","unstructured":"Rodgers J, Ashton CH, Gilvarry E, Young AH (2004) Liquid ecstasy: a new kid on the dance floor. Br J Psychiatry 184:104\u2013106","journal-title":"Br J Psychiatry"},{"key":"718_CR28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1476-5381.1990.tb14186.x","volume":"101","author":"GR Seabrook","year":"1990","unstructured":"Seabrook GR, Howson W, Lacey MG (1990) Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices. Br J Pharmacol 101:949\u2013957","journal-title":"Br J Pharmacol"},{"key":"718_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejphar.2003.10.045","volume":"483","author":"RJ Sevak","year":"2004","unstructured":"Sevak RJ, France CP, Koek W (2004) Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine. Eur J Pharmacol 483:289\u2013293","journal-title":"Eur J Pharmacol"},{"key":"718_CR30","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/0006-2952(84)90629-4","volume":"33","author":"OC Snead III","year":"1984","unstructured":"Snead OC III, Liu CC (1984) Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 33:2587\u20132590","journal-title":"Biochem Pharmacol"},{"key":"718_CR31","doi-asserted-by":"crossref","DOI":"10.1201\/9781420036107","volume-title":"Drug synergism and dose\u2013effect data analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug synergism and dose\u2013effect data analysis. CRC, Boca Raton"},{"key":"718_CR32","first-page":"278","volume":"3","author":"G Tunnicliff","year":"2002","unstructured":"Tunnicliff G, Raess BU (2002) Gamma-Hydroxybutyrate (orphan medical). Curr Opin Investig Drugs 3:278\u2013283","journal-title":"Curr Opin Investig Drugs"},{"key":"718_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00168606","volume":"343","author":"PC Waldmeier","year":"1991","unstructured":"Waldmeier PC (1991) The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn-Schmiedebergs Arch Pharmakol 343:173\u2013178","journal-title":"Naunyn-Schmiedebergs Arch Pharmakol"},{"key":"718_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/BF00426468","volume":"73","author":"JC Winter","year":"1981","unstructured":"Winter JC (1981) The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology (Berl) 73:372\u2013375","journal-title":"Psychopharmacology (Berl)"},{"key":"718_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","volume":"25","author":"CG Wong","year":"2004","unstructured":"Wong CG, Gibson KM, Snead OC III (2004) From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25:29\u201334","journal-title":"Trends Pharmacol Sci"},{"key":"718_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0006-8993(87)90547-6","volume":"422","author":"U Wullner","year":"1987","unstructured":"Wullner U, Klockgether T, Schwarz M, Sontag KH (1987) Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate. Brain Res 422:129\u2013136","journal-title":"Brain Res"},{"key":"718_CR37","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1152\/jn.1999.81.6.2875","volume":"81","author":"K Yamada","year":"1999","unstructured":"Yamada K, Yu B, Gallagher JP (1999) Different subtypes of GABAB receptors are present at pre-and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol 81:2875\u20132883","journal-title":"J Neurophysiol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0718-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-007-0718-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0718-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0718-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:19:46Z","timestamp":1652833186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-007-0718-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0718-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,3]]},"assertion":[{"value":"31 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}